Mitsubishi UFJ Trust and Banking Corporation
Location
Founded
1984-04-23
Website
Risk Signals
197 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Banks, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Mitsubishi UFJ Trust and Banking Corporation
Live alerts from global media, monitored by Business Radar
2025-04-13 (marketbeat.com)
Arrowstreet Capital Limited Partnership Acquires New Holdings in AMC Networks Inc. (NASDAQ:AMCX)
Arrowstreet Capital Limited Partnership purchased a new stake in AMC Networks Inc. (NASDAQ:AMCX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 63,698 shares of the company's stock, valued at
Read more
2025-04-03 (marketbeat.com)
Mitsubishi UFJ Trust & Banking Corp Buys New Position in Kite Realty Group Trust (NYSE:KRG)
Mitsubishi UFJ Trust & Banking Corp acquired a new stake in shares of Kite Realty Group Trust (NYSE:KRG - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 13,790 shares of the real estate investment trust's stock, valued at
Read more
2025-03-31 (reporter.am)
Mitsubishi UFJ Trust & Banking Corp Raises Stake in Carter's, Inc. (NYSE:CRI) -
Read Mitsubishi UFJ Trust & Banking Corp Raises Stake in Carter's, Inc. (NYSE:CRI) at The AM Reporter
Read more
2025-03-26 (marketbeat.com)
Mitsubishi UFJ Trust & Banking Corp Has $70.40 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)
Mitsubishi UFJ Trust & Banking Corp lowered its stake in Amgen Inc. (NASDAQ:AMGN - Free Report) by 17.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 270,089 shares of the medical research company's stock after selling
Read more